Nadya G. Avakumova-Hristova
Sofia, 1431, Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of Chlorine and Methyl Substitution on Structure, IR, and Raman Spectra of the Biomolecule 6-Chloro-3-methyluracil in Isolated and Solid States and in Base-Pair Formation.
Journal: Molecules (Basel, Switzerland)
Published: June 26, 2026
High-Frequency Immersed Plasma: Reactive Species Generation, Redox Transformations, and Competing Chemical Processes in Iron-Induced Oxidative Degradation in a Deoxyribose Model System.
Journal: International journal of molecular sciences
Published: April 02, 2026
Gastrointestinal Cancers with Consideration of DPD and UGT1A1 Plasma Levels: Chemotherapy-Related Toxicity.
Journal: Life (Basel, Switzerland)
Published: May 05, 2025
Exploring the Potential of Indole-3-acetic Acid Arylhydrazone Hybrids for Parkinson's Disease Treatment: A Comprehensive Evaluation of Neuroprotective, MAOB Inhibitory, and Antioxidant Properties.
Journal: ACS chemical neuroscience
Published: March 11, 2025
Molecular properties of a triazole-Ce(III) complex with antioxidant activity: structure, spectroscopy, and relationships with related derivatives. Influence of the ligands in the complex.
Journal: Frontiers in chemistry
Published: June 16, 2024
New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors.
Journal: Antioxidants (Basel, Switzerland)
Published: February 19, 2023
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: March 15, 2022
New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity.
Journal: RSC advances
Published: October 06, 2021
Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.
Journal: Neural regeneration research
Published: April 05, 2021
Does dihydropyrimidine dehydrogenase level modify plasma antioxidant capacity in colorectal cancer patients treated with fluoropyrimidines?
Journal: Folia medica
Published: August 04, 2020
Antitumor activity of the combination of artemisinin and epirubicin in human leukemia cells.
Journal: Folia medica
Published: June 28, 2020
New benzimidazole-aldehyde hybrids as neuroprotectors with hypochlorite and superoxide radical-scavenging activity.
Journal: Pharmacological reports : PR
Published: July 17, 2019
Last Updated: 09/26/2026